Terms: = Lung cancer AND ZFHX3, ATBT, 463, ENSG00000140836, Q15911 AND Treatment
66 results:
1. Influence of
Naqash AR; Floudas CS; Aber E; Maoz A; Nassar AH; Adib E; Choucair K; Xiu J; Baca Y; Ricciuti B; Alessi JV; Awad MM; Kim C; Judd J; Raez LE; Lopes G; Nieva JJ; Borghaei H; Takebe N; Ma PC; Halmos B; Kwiatkowski DJ; Liu SV; Mamdani H
JCO Precis Oncol; 2024 Feb; 8():e2300371. PubMed ID: 38330261
[TBL] [Abstract] [Full Text] [Related]
2. Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies.
Liu Q; Zhang J; Guo C; Wang M; Wang C; Yan Y; Sun L; Wang D; Zhang L; Yu H; Hou L; Wu C; Zhu Y; Jiang G; Zhu H; Zhou Y; Fang S; Zhang T; Hu L; Li J; Liu Y; Zhang H; Zhang B; Ding L; Robles AI; Rodriguez H; Gao D; Ji H; Zhou H; Zhang P
Cell; 2024 Jan; 187(1):184-203.e28. PubMed ID: 38181741
[TBL] [Abstract] [Full Text] [Related]
3. Is chest imaging needed as part of pT1a renal cell carcinoma surveillance after surgical resection?
Charles D; Fitzgerald J; Landowski T; Cooper B; Yong R; Everett R; See W; Jacobsohn K; Johnson S; Langenstroer P
Urol Oncol; 2024 Jan; 42(1):23.e1-23.e4. PubMed ID: 38040536
[TBL] [Abstract] [Full Text] [Related]
4. Perspectives, risk factors, and coping mechanisms in patients with self-reported financial burden following lung cancer surgery.
Deboever N; Eisenberg MA; Antonoff MB; Hofstetter WL; Mehran RJ; Rice DC; Roth JA; Sepesi B; Swisher SG; Vaporciyan AA; Walsh GL; Rajaram R
J Thorac Cardiovasc Surg; 2024 Feb; 167(2):478-487.e2. PubMed ID: 37356476
[TBL] [Abstract] [Full Text] [Related]
5. Artificial intelligence-quantified tumour-lymphocyte spatial interaction predicts disease-free survival in resected lung adenocarcinoma: A graph-based, multicentre study.
Feng Z; Lin H; Liu Z; Yan L; Wang Y; Li B; Liu E; Han C; Shi Z; Lu C; Liu Z; Pang C; Li Z; Cui Y; Pan X; Chen X
Comput Methods Programs Biomed; 2023 Aug; 238():107617. PubMed ID: 37235970
[TBL] [Abstract] [Full Text] [Related]
6. Regional lymph node recurrence after stereotactic body radiation therapy for lung cancer: Patterns of recurrence, treatment approaches, and clinical outcomes (KROG 21-09).
Lee TH; Shin H; Ahn YC; Kang MK; Song C; Kim WC; Moon SH; Kim JH; Cho J; Park HJ; Lee HK; Kim BH; Kim HJ
Radiother Oncol; 2023 Jun; 183():109572. PubMed ID: 36822359
[TBL] [Abstract] [Full Text] [Related]
7. Identification and validation of a genomic mutation signature as a predictor for immunotherapy in NSCLC.
Wang Z; Ge Y; Li H; Fei G; Wang S; Wei P
Biosci Rep; 2022 Nov; 42(11):. PubMed ID: 36305643
[TBL] [Abstract] [Full Text] [Related]
8. Patients deriving long-term benefit from immune checkpoint inhibitors demonstrate conserved patterns of site-specific mutations.
Principe DR
Sci Rep; 2022 Jul; 12(1):11490. PubMed ID: 35798829
[TBL] [Abstract] [Full Text] [Related]
9. Real-world treatment patterns of metastatic non-small cell lung cancer patients receiving epidermal growth factor receptor tyrosine kinase inhibitors.
Shenolikar R; Liu S; Shah A; Tse J; Cao Y; Near A
Cancer Med; 2023 Jan; 12(1):159-169. PubMed ID: 35702932
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic value of pre-treatment advanced lung cancer inflammation index in non-small cell lung cancer: a meta-analysis.
Tang Y; Ji Y; Yang M
Biomarkers; 2022 Jul; 27(5):441-447. PubMed ID: 35297277
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic effect of coexisting TP53 and zfhx3 mutations in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
Zhang L; Zhang T; Shang B; Li Y; Cao Z; Wang H
Scand J Immunol; 2021 Sep; 94(3):e13087. PubMed ID: 35226388
[TBL] [Abstract] [Full Text] [Related]
12. Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis.
Goldinger SM; Buder-Bakhaya K; Lo SN; Forschner A; McKean M; Zimmer L; Khoo C; Dummer R; Eroglu Z; Buchbinder EI; Ascierto PA; Gutzmer R; Rozeman EA; Hoeller C; Johnson DB; Gesierich A; Kölblinger P; Bennannoune N; Cohen JV; Kähler KC; Wilson MA; Cebon J; Atkinson V; Smith JL; Michielin O; Long GV; Hassel JC; Weide B; Haydu LE; Schadendorf D; McArthur G; Ott PA; Blank C; Robert C; Sullivan R; Hauschild A; Carlino MS; Garbe C; Davies MA; Menzies AM
Eur J Cancer; 2022 Feb; 162():22-33. PubMed ID: 34952480
[TBL] [Abstract] [Full Text] [Related]
13. Immune checkpoint inhibitor-related adverse events in lung cancer: Real-world incidence and management practices of 1905 patients in China.
Shi Y; Fang J; Zhou C; Liu A; Wang Y; Meng Q; Ding C; Ai B; Gu Y; Yao Y; Sun H; Guo H; Zhang C; Song X; Li J; Xu B; Han Z; Song M; Tang T; Chen P; Lu H; Shui Y; Lou G; Zhang D; Liu J; Liu X; Liu X; Gao X; Zhou Q; Chen M; Zhao J; Zhong W; Xu Y; Wang M
Thorac Cancer; 2022 Feb; 13(3):412-422. PubMed ID: 34935288
[TBL] [Abstract] [Full Text] [Related]
14. Age and Gender Specific lung cancer Incidence and Mortality in Hungary: Trends from 2011 Through 2016.
Tamási L; Horváth K; Kiss Z; Bogos K; Ostoros G; Müller V; Urbán L; Bittner N; Sárosi V; Vastag A; Polányi Z; Nagy-Erdei Z; Daniel A; Nagy B; Rokszin G; Abonyi-Tóth Z; Moldvay J; Vokó Z; Gálffy G
Pathol Oncol Res; 2021; 27():598862. PubMed ID: 34257553
[No Abstract] [Full Text] [Related]
15. Effect of renin-angiotensin system inhibitors on pemetrexed plus platinum-induced hematological toxicities: a multicenter retrospective study using three propensity score analyses.
Arami T; Kawazoe H; Uozumi R; Hashimoto H; Egami S; Sakiyama N; Ohe Y; Nakada H; Aomori T; Ikemura S; Yasuda H; Kawada I; Fukunaga K; Soejima K; Yamaguchi M; Nakamura T
Pharmazie; 2021 Jun; 76(6):266-271. PubMed ID: 34078521
[TBL] [Abstract] [Full Text] [Related]
16. Comparative Effectiveness of Machine Learning Approaches for Predicting Gastrointestinal Bleeds in Patients Receiving Antithrombotic treatment.
Herrin J; Abraham NS; Yao X; Noseworthy PA; Inselman J; Shah ND; Ngufor C
JAMA Netw Open; 2021 May; 4(5):e2110703. PubMed ID: 34019087
[TBL] [Abstract] [Full Text] [Related]
17. CT-Guided Microcoil Localization of Small Peripheral Pulmonary Nodules to Direct Video-Assisted Thoracoscopic Resection without the Aid of Intraoperative Fluoroscopy.
Huang ZG; Wang CL; Sun HL; Li CD; Gao BX; Chen H; Yang MX
Korean J Radiol; 2021 Jul; 22(7):1124-1131. PubMed ID: 33856129
[TBL] [Abstract] [Full Text] [Related]
18. A retrospective analysis of pembrolizumab plus chemotherapy versus pembrolizumab monotherapy for advanced or recurrent non-small cell lung cancer.
Isono T; Kagiyama N; Shibata S; Nakajima H; Matsui Y; Takano K; Nishida T; Hosoda C; Kawate E; Kobayashi Y; Ishiguro T; Takaku Y; Kurashima K; Yanagisawa T; Takayanagi N
Thorac Cancer; 2021 May; 12(9):1387-1397. PubMed ID: 33710764
[TBL] [Abstract] [Full Text] [Related]
19. Evolution of Systemic treatment Uptake and Survival in Advanced Non-Small Cell lung cancer.
Stock-Martineau S; Laurie K; McKinnon M; Zhang T; Wheatley-Price P
Curr Oncol; 2020 Dec; 28(1):60-68. PubMed ID: 33704175
[TBL] [Abstract] [Full Text] [Related]
20. Cost-effectiveness of Osimertinib vs Docetaxel-bevacizumab in Third-line treatment in EGFR T790M Resistance Mutation Advanced Non-Small Cell lung cancer in China.
Rui M; Li H
Clin Ther; 2020 Nov; 42(11):2159-2170.e6. PubMed ID: 33028495
[TBL] [Abstract] [Full Text] [Related]
[Next]
